US98978V1035 - Common Stock
ZOETIS INC
NYSE:ZTS (5/3/2024, 7:04:00 PM)
After market: 167.07 0 (0%)167.07
-0.16 (-0.1%)
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The company is headquartered in Parsippany, New Jersey and currently employs 13,800 full-time employees. The company went IPO on 2013-02-01. The firm is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health technology. The company commercializes products across eight core species: dogs, cats and horses and cattle, swine, poultry, fish and sheep and within product categories, such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The firm operates through two segments: the United States and International. Within each of these operating segments, it offers a product portfolio for both companion animal and livestock customers. The firm market its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company’s products are sold in more than 100 countries.
ZOETIS INC
10 Sylvan Way
Parsippany NEW JERSEY 07054
P: 19738227000
CEO: Kristin C. Peck
Employees: 13800
Website: https://www.zoetis.com/
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of...
ZTS earnings call for the period ending March 31, 2024.
An estimates-beating quarter and raised guidance made the company a pet stock for many investors.
Stay informed about the performance of the S&P500 index in the middle of the day on Thursday. Uncover the top gainers and losers in today's session for valuable insights.
ZTS stock results show that Zoetis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Here you can normally see the latest stock twits on ZTS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: